Dr Reddy’s is currently trading at Rs. 1679.00, up by 7.00 points or 0.42% from its previous closing of Rs. 1672.00 on the BSE.
The scrip opened at Rs. 1687.00 and has touched a high and low of Rs. 1697.95 and Rs. 1673.90 respectively. So far 12,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1818.00 on 20-Apr-2012 and a 52 week low of Rs. 1387.00 on 22-Aug-2011.
Last one week high and low of the scrip stood at Rs. 1725.00 and Rs. 1637.15 respectively. The current market cap of the company is Rs. 28,487 crore.
The promoters holding in the company stood at 25.57% while Institutions and Non-Institutions held 40.32% and 17.32% respectively.
Dr Reddy’s laboratories has launched Atorvastation Calcium tablets 10 mg, 20mg, 40 mg and 80 mg a bioequivalent generic version of LIPITOR tablets in the US market on July 17, 2012 following the approval by the United State Food & Drug Administration ( USFDA).
The company’s Atorvastation Calcium tablets 10 mg, 20mg, 40 mg and 80 mg are available in bottle count size of 90 and 500.
The LIPITOR brand had US sales of approximately $ 8.07billion for the most recent twelve months ending March 2012 according to IMS Health.
Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1814.50 |
Dr. Reddys Lab | 1340.80 |
Cipla | 1476.45 |
Lupin | 2160.20 |
Zydus Lifesciences | 972.95 |
View more.. |